|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.806
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.686
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.585
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.503
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.460
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.440
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.346
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.327
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.307
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.306
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.280
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.278
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.246
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.205
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.196
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.182
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.172
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.171
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.170
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.148
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.147
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.135
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.122
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.120
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.108
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.105
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.104
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.102
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.099
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.093
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.093
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.090
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.087
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.087
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.086
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.085
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.084
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
23 |
0.084
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.084
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.081
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.077
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.077
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.076
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.075
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.075
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.071
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.071
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.071
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.071
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.068
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.065
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.064
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.064
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.063
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.063
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.062
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.060
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.059
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.057
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.057
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.056
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.056
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.054
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.053
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.052
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.052
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.052
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.051
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.051
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.051
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.051
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.051
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.051
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.051
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.050
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.050
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.050
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.049
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.049
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.047
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.046
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.045
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.044
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.043
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.043
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.043
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.043
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.043
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.043
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.042
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.041
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.041
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.041
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.041
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.041
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.040
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.040
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.040
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.040
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.039
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.039
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.039
|
|
|
|
regulation of mrna 3 end processing
|
GO:0031440 |
6 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
Mouse |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.038
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.037
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.037
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.037
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.037
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.037
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.037
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.037
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.037
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.036
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.036
|
|
|
|
long term memory
|
GO:0007616 |
15 |
0.036
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.036
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.036
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.036
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.035
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.035
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.035
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.035
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.035
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.034
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.034
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.034
|
|
|
|
memory
|
GO:0007613 |
58 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.034
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.034
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.033
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.033
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.033
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.033
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.033
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.033
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.033
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.032
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.032
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.032
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.032
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.032
|
Mouse |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.031
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.031
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.031
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.031
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.030
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.030
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.030
|
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.030
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.029
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.029
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.029
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.029
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.029
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.029
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.028
|
Mouse |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.028
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.028
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.028
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.028
|
|
|
|
positive regulation of interleukin 5 secretion
|
GO:2000664 |
1 |
0.028
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.027
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.027
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.027
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.027
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.027
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.027
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.027
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.026
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.026
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.026
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.026
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.026
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.026
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.026
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.025
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.025
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.025
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.025
|
|
|
|
positive regulation of chromosome segregation
|
GO:0051984 |
4 |
0.025
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.025
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.025
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.025
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.024
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.024
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.024
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.024
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.024
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.024
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.024
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.024
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.024
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.024
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.024
|
Mouse |
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.024
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.024
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.023
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.023
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.023
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.023
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.023
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.022
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.022
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.022
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.022
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.022
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.022
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.022
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.022
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.022
|
Mouse |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.021
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.021
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.021
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.021
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.020
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.020
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.020
|
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
2 |
0.020
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.020
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.020
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.020
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.020
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.020
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.020
|
|
|
|
regulation of dna dependent dna replication
|
GO:0090329 |
8 |
0.020
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.020
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.019
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.019
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.019
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.019
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.019
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.019
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.019
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.019
|
|
|
|
regulation of mrna polyadenylation
|
GO:1900363 |
1 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.019
|
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.019
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.019
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.019
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.018
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.018
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.018
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.018
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.018
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.018
|
Mouse |
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.018
|
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.018
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.018
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.017
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.017
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.017
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.017
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.017
|
|
|
|
regulation of ral gtpase activity
|
GO:0032315 |
4 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.017
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.017
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.017
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.017
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.017
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.017
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.017
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.016
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway
|
GO:0043162 |
3 |
0.016
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.016
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.016
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.016
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.016
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.016
|
|
|
|
learning
|
GO:0007612 |
98 |
0.016
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.016
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.016
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.016
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.016
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.016
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.016
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.015
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.015
|
|
|
|
stem cell fate determination
|
GO:0048867 |
2 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.015
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.015
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.015
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.015
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.015
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.015
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.015
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.015
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.015
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.015
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.015
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.015
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.015
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.015
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.015
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.015
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.015
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.015
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.015
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.015
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.015
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.015
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.015
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.015
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.015
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.014
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.014
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.014
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.014
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.014
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.014
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.014
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.014
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
10 |
0.014
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.014
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.014
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.014
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.014
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.014
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.014
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.014
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.014
|
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.014
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.014
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.014
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.014
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.014
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.014
|
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.014
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.013
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.013
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.013
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.013
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.013
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.013
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.013
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.013
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.013
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.013
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.013
|
|
|
|
inositol phosphate mediated signaling
|
GO:0048016 |
13 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
|
